(CNO) CNO Financial - NYSE
Sector: Financial Services | Industry: Insurance - Life | Exchange: NYSE (USA) | Market Cap: 4.701m USD | Total Return: 35.9% in 12m
Avg Turnover: 29.1M
EPS Trend: 88.6%
Qual. Beats: -1
Rev. Trend: 83.4%
Qual. Beats: 0
Warnings
Extended 1w
Tailwinds
Supp Ema20
CNO Financial Group, Inc. is a Carmel, Indiana-based financial services holding company that develops and markets health insurance, annuities, and life insurance products. The firm primarily targets middle-income pre-retirees and retirees in the United States through its three primary brands: Bankers Life, Washington National, and Colonial Penn.
The company utilizes a multi-channel distribution strategy, utilizing captive agents, independent producers, and direct-to-consumer digital platforms. In the Life & Health Insurance sector, firms often rely on the spread between investment income from premium reserves and the cost of insurance claims to drive profitability. CNO specifically focuses on the worksite market and individual retiree segments, offering specialized products like Medicare Supplement and long-term care insurance.
Investors can evaluate the underlying valuation metrics of this insurance provider by reviewing the data on ValueRay. The companys business model integrates voluntary employer-sponsored benefits with individual retail sales to maintain a diversified revenue stream across its product portfolio.
- Rising interest rates improve investment income yields on fixed annuity portfolios
- Middle-income demographic growth drives demand for Medicare supplement and life insurance
- Claims volatility in long-term care insurance segments impacts quarterly earnings stability
- Direct-to-consumer marketing efficiency at Colonial Penn influences customer acquisition costs
- Expansion of worksite voluntary benefits portfolio diversifies revenue beyond individual retirees
| Net Income: 245.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA -0.02 > 1.0 |
| NWC/Revenue: -400.4% < 20% (prev -80.39%; Δ -320.0% < -1%) |
| CFO/TA 0.02 > 3% & CFO 687.8m > Net Income 245.5m |
| Net Debt (-5.09b) to EBITDA (638.1m): -7.97 < 3 |
| Current Ratio: 0.06 > 1.5 & < 3 |
| Outstanding Shares: last quarter (94.1m) vs 12m ago -8.72% < -2% |
| Gross Margin: 42.28% > 18% (prev 39.49%; Δ 2.79% > 0.5%) |
| Asset Turnover: 11.82% > 50% (prev 11.48%; Δ 0.34% > 0%) |
| Interest Coverage Ratio: 1.43 > 6 (EBIT TTM 314.0m / Interest Expense TTM 219.8m) |
| A: -0.46 (Total Current Assets 1.15b - Total Current Liabilities 19.2b) / Total Assets 38.9b |
| B: 0.06 (Retained Earnings 2.44b / Total Assets 38.9b) |
| C: 0.01 (EBIT TTM 314.0m / Avg Total Assets 38.2b) |
| D: 0.07 (Book Value of Equity 2.50b / Total Liabilities 36.5b) |
| Altman-Z'' = -2.72 = D |
| DSRI: 0.91 (Receivables 4.64b/4.87b, Revenue 4.51b/4.30b) |
| GMI: 0.93 (GM 39.49% / 42.28%) |
| AQI: 1.56 (AQ_t 0.97 / AQ_t-1 0.62) |
| SGI: 1.05 (Revenue 4.51b / 4.30b) |
| TATA: -0.01 (NI 245.5m - CFO 687.8m) / TA 38.9b) |
| Beneish M = -2.79 (Cap -4..+1) = A |
As of June 13, 2026, the stock is trading at USD 50.36 with a total of 354,025 shares traded.
Over the past week, the price has changed by +5.50%,
over one month by +9.48%,
over three months by +27.10% and
over the past year by +35.94%.
CNO Financial has received a consensus analysts rating of 3.00. Therefore, it is recommended to hold CNO.
- StrongBuy: 1
- Buy: 0
- Hold: 3
- Sell: 0
- StrongSell: 1
| Analysts Target Price | 49.5 | -1.7% |
P/E Trailing = 20.3065
P/E Forward = 9.7087
P/S = 1.0417
P/B = 1.867
P/EG = 1.287
Revenue TTM = 4.51b USD
EBIT TTM = 314.0m USD
EBITDA TTM = 638.1m USD
Long Term Debt = 4.30b USD (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = 4.30b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -5.09b USD (calculated: Debt 4.30b - CCE 9.39b)
Enterprise Value = 4.70b USD (floored to Market Cap, CCE > MCap+Debt)
Interest Coverage Ratio = 1.43 (Ebit TTM 314.0m / Interest Expense TTM 219.8m)
EV/FCF = 6.83x (Enterprise Value 4.70b / FCF TTM 687.8m)
FCF Yield = 14.63% (FCF TTM 687.8m / Enterprise Value 4.70b)
FCF Margin = 15.24% (FCF TTM 687.8m / Revenue TTM 4.51b)
Net Margin = 5.44% (Net Income TTM 245.5m / Revenue TTM 4.51b)
Gross Margin = 42.28% ((Revenue TTM 4.51b - Cost of Revenue TTM 2.60b) / Revenue TTM)
Gross Margin QoQ = 44.63% (prev 47.27%)
Tobins Q-Ratio = 0.12 (Enterprise Value 4.70b / Total Assets 38.9b)
Interest Expense / Debt = 5.11% (Interest Expense 219.8m / Debt 4.30b)
Taxrate = 21.82% (68.5m / 314.0m)
NOPAT = 245.5m (EBIT 314.0m * (1 - 21.82%))
Current Ratio = 0.06 (Total Current Assets 1.15b / Total Current Liabilities 19.2b)
Debt / Equity = 1.72 (Debt 4.30b / totalStockholderEquity, last quarter 2.50b)
Debt / EBITDA = -7.97 (Net Debt -5.09b / EBITDA 638.1m)
Debt / FCF = -7.39 (Net Debt -5.09b / FCF TTM 687.8m)
Total Stockholder Equity = 2.57b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.64% (Net Income 245.5m / Total Assets 38.9b)
RoE = 9.56% (Net Income TTM 245.5m / Total Stockholder Equity 2.57b)
RoCE = 4.57% (EBIT 314.0m / Capital Employed (Equity 2.57b + L.T.Debt 4.30b))
RoIC = 1.26% (NOPAT 245.5m / Invested Capital 19.5b)
WACC = 6.32% (E(4.70b)/V(9.00b) * Re(8.45%) + D(4.30b)/V(9.00b) * Rd(5.11%) * (1-Tc(0.22)))
Discount Rate = 8.45% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -94.39 | Cagr: -8.06%
[DCF] Terminal Value 75.79% ; FCFF base≈680.6m ; Y1≈698.7m ; Y5≈773.6m
[DCF] Fair Price = 182.8 (EV 12.0b - Net Debt -5.09b = Equity 17.1b / Shares 93.3m; r=8.35% [WACC [floored]]; 5y FCF grow 2.69% → 2.50% )
EPS Correlation: 88.59 | EPS CAGR: 26.25% | SUE: -3.07 | # QB: -1
Revenue Correlation: 83.43 | Revenue CAGR: 4.68% | SUE: 0.12 | # QB: 0
EPS current Quarter (2026-06-30): EPS=1.00 | Chg30d=-1.96% | Revisions=+0% | Analysts=2
EPS next Quarter (2026-09-30): EPS=1.08 | Chg30d=-1.36% | Revisions=-20% | Analysts=2
EPS current Year (2026-12-31): EPS=4.48 | Chg30d=+2.05% | Revisions=+33% | GrowthEPS=+1.8% | GrowthRev=-9.5%
EPS next Year (2027-12-31): EPS=4.95 | Chg30d=+1.14% | Revisions=+33% | GrowthEPS=+10.6% | GrowthRev=+3.4%
[Analyst] Revisions Ratio: +33%